predi TY - T1的肺血管阻力cts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01483-2021 VL - 58 IS - 2 SP - 2101483 AU - Olsson, Karen M. AU - Hoeper, Marius M. AU - Pausch, Christine AU - Grünig, Ekkehard AU - Huscher, Doerte AU - Pittrow, David AU - Rosenkranz, Stephan AU - Gall, Henning Y1 - 2021/08/01 UR - //www.qdcxjkg.com/content/58/2/2101483.abstract N2 - Pulmonary hypertension (PH) is a common complication of many chronic lung diseases, especially COPD and interstitial lung disease (ILD) [1]. In these conditions, the development of PH is associated with an aggravation of symptoms and an increase in mortality risk. In most patients with chronic lung disease, the haemodynamic severity of PH is mild to moderate, while some patients develop severe PH, which is presently defined by a mean pulmonary arterial pressure (mPAP) ≥35 mmHg or mPAP ≥25 mmHg in the presence of a cardiac index <2.0 L·min−1·m−2 [2]. These haemodynamic criteria were introduced per expert consensus but were not based on solid data.In patients with pulmonary hypertension associated with interstitial lung disease, pulmonary vascular resistance provides stronger prognostic information than mean pulmonary arterial pressure https://bit.ly/3w1QcISThe authors are indebted to the COMPERA investigators and their co-workers. ER -